Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
A-2B530 by A2 Biotherapeutics for Metastatic Colorectal Cancer: Likelihood of Approval
A-2B530 is under clinical development by A2 Biotherapeutics and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...